<p>Emerald Mutual Fund Advisers Trust 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第三季度削減了其在 Omada Health, Inc.（NASDAQ:OMDA - 免費報告）股票的持有量，減少幅度為 61.6%。該機構投資者在此期間售出了 99,302 股後，持有 61,925 股公司的股票。截至其最近向證券交易委員會（SEC）提交的文件，Emerald Mutual Fund Advisers Trust 持有的 Omada Health 股票約佔 0.11%，價值 1,369,000 美元。</p>
<p>其他機構投資者也對該公司的股份進行了增持或減持。Raymond James Financial Inc. 在第二季度購買了價值約 32,000 美元的 Omada Health 新股份。Rakuten Investment Management Inc. 在第三季度購買了價值約 49,000 美元的 Omada Health 新頭寸。Ilex Capital Partners UK LLP 在第二季度購買了價值 201,000 美元的 Omada Health 新股份。Wilmington Savings Fund Society FSB 在第三季度購買了價值 287,000 美元的 Omada Health 新股份。最後，Sandia Investment Management LP 在第二季度購買了價值 366,000 美元的 Omada Health 新股份。</p>
<h2>分析師設定新目標價</h2>
<p>幾位研究分析師最近對該公司發表了評論。巴克萊將 Omada Health 的目標價從 29.00 美元下調至 22.00 美元，並在 1 月 5 日的研究報告中給予該公司 “增持” 評級。高盛集團重申了對 Omada Health 的 “買入” 評級，並在 1 月 16 日的報告中發佈了 26.00 美元的目標價。Needham &amp; Company LLC 在週四重申了 “買入” 評級，並對 Omada Health 發佈了 28.00 美元的目標價。富國銀行在 1 月 8 日的研究報告中開始覆蓋 Omada Health 的股票，給予 “持平” 評級，目標價為 17.00 美元。最後，BMO Capital Markets 在 11 月 13 日的研究報告中開始覆蓋 Omada Health 的股票，設定了 “跑贏大盤” 評級和 27.00 美元的目標價。八位投資分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，Omada Health 目前的平均評級為 “適度買入”，共識目標價為 25.10 美元。</p>
<p><strong>查看我們關於 Omada Health 的最新研究報告</strong></p>
<h2>Omada Health 股票表現</h2>
<p>Omada Health 股票在週五開盤價為 16.52 美元。該股票的市值為 9.5667 億美元，市盈率為 -66.08。該股票的 50 日移動平均線為 16.38 美元，200 日移動平均線為 19.88 美元。Omada Health, Inc. 的一年低點為 14.14 美元，一年高點為 28.40 美元。</p>
<h2>內部交易活動</h2>
<p>在其他 Omada Health 的新聞中，總裁 Wei-Li Shao 於 12 月 29 日星期一出售了 5,618 股公司的股票。該股票以平均價格 16.13 美元出售，總交易額為 90,618.34 美元。出售後，總裁持有 69,079 股公司的股票，價值約 1,114,244.27 美元。此次交易使其持股減少了 7.52%。該交易已在向證券交易委員會提交的文件中披露，相關文件可在此鏈接查看。此外，首席執行官 Sean P. Duffy 於 1 月 12 日星期一出售了 230,479 股公司的股票。該股票以平均價格 15.60 美元出售，總交易額為 3,595,472.40 美元。交易後，首席執行官持有 126,644 股公司的股票，價值 1,975,646.40 美元。此次交易使其持股減少了 64.54%。有關此次出售的更多細節可在官方 SEC 披露中找到。在過去 90 天內，內部人士已出售了價值 4,336,787 美元的 276,893 股公司股票。</p>
<h2>Omada Health 公司簡介</h2>
<p>（免費報告）</p>
<p>Omada Health 是一家數字健康公司，專注於通過個性化的技術驅動程序預防和管理慢性疾病。該公司的平台結合了數據分析、行為科學和人類輔導，以支持面臨風險或患有如前糖尿病、2 型糖尿病、高血壓和肌肉骨骼疾病等疾病的個體。參與者通過移動應用程序或網絡門户訪問該程序，在那裏他們可以獲得量身定製的課程、健康指標反饋和持續的虛擬輔導。</p>
<p>除了核心的疾病管理服務外，Omada Health 還擴展了其服務，包括心理健康支持和數字治療以幫助體重管理。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票比 Omada Health 更好</li>
<li>投資者警報：微小的 “3 美元 AI 奇蹟股票” 即將爆發</li>
<li>沒有人告訴你的 100 萬億美元的 AI 故事</li>
<li>在週一上午 9:30 買入這隻股票！</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
<li>埃隆將 SpaceX 上市！100 美元的 IPO 前機會！</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Omada Health 嗎？</h2>
<p>在你考慮 Omada Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前買入……而 Omada Health 並不在名單上。</p>
<p>雖然 Omada Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得投資。</p>
<p>在這裏查看五隻股票</p>

美國醫療保健供應商 ETF - iShares

美國醫藥設備 ETF - iShares

OMDA

標普醫療保健服務 ETF - SPDR

標普健康醫療設備 ETF - SPDR

<p>Emerald Mutual Fund Advisers Trust 在第三季度減少了對 Omada Health, Inc. (NASDAQ:OMDA) 的持股比例，減持了 61.6%，出售了 99,302 股，保留了價值約 137 萬美元的 61,925 股。其他機構投資者也調整了他們的持倉。分析師為 Omada Health 設置了新的價格目標，巴克萊將其下調至 22.00 美元，而高盛則維持在 26.00 美元。該股票開盤價為 16.52 美元，市值為 9.5667 億美元。內部人士的銷售包括總裁 Wei-Li Shao 和首席執行官 Sean P. Duffy 的重大交易</p>

<p>Emerald Mutual Fund Advisers Trust trimmed its holdings in shares of Omada Health, Inc. (NASDAQ:OMDA - Free Report) by 61.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,925 shares of the company's stock after selling 99,302 shares during the period. Emerald Mutual Fund Advisers Trust owned about 0.11% of Omada Health worth $1,369,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Emerald Mutual Fund Advisers Trust 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第三季度削減了其在 Omada Health, Inc.（NASDAQ:OMDA - 免費報告）股票的持有量，減少幅度為 61.6%。該機構投資者在此期間售出了 99,302 股後，持有 61,925 股公司的股票。截至其最近向證券交易委員會（SEC）提交的文件，Emerald Mutual Fund Advisers Trust 持有的 Omada Health 股票約佔 0.11%，價值 1,369,000 美元。</p>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new stake in shares of Omada Health in the 2nd quarter worth approximately $32,000. Rakuten Investment Management Inc. bought a new position in Omada Health in the third quarter worth approximately $49,000. Ilex Capital Partners UK LLP purchased a new stake in Omada Health during the second quarter worth $201,000. Wilmington Savings Fund Society FSB bought a new stake in Omada Health during the 3rd quarter valued at $287,000. Finally, Sandia Investment Management LP bought a new stake in Omada Health during the 2nd quarter valued at $366,000.</p>
<div class="lb-trans"><p>其他機構投資者也對該公司的股份進行了增持或減持。Raymond James Financial Inc. 在第二季度購買了價值約 32,000 美元的 Omada Health 新股份。Rakuten Investment Management Inc. 在第三季度購買了價值約 49,000 美元的 Omada Health 新頭寸。Ilex Capital Partners UK LLP 在第二季度購買了價值 201,000 美元的 Omada Health 新股份。Wilmington Savings Fund Society FSB 在第三季度購買了價值 287,000 美元的 Omada Health 新股份。最後，Sandia Investment Management LP 在第二季度購買了價值 366,000 美元的 Omada Health 新股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several research analysts have recently commented on the company. Barclays reduced their price target on Omada Health from $29.00 to $22.00 and set an &#34;overweight&#34; rating for the company in a research report on Monday, January 5th. The Goldman Sachs Group reiterated a &#34;buy&#34; rating and issued a $26.00 target price on shares of Omada Health in a report on Friday, January 16th. Needham &amp; Company LLC restated a &#34;buy&#34; rating and issued a $28.00 price target on shares of Omada Health in a report on Thursday. Wells Fargo &amp; Company began coverage on shares of Omada Health in a research report on Thursday, January 8th. They issued an &#34;equal weight&#34; rating and a $17.00 price objective on the stock. Finally, BMO Capital Markets began coverage on shares of Omada Health in a research note on Thursday, November 13th. They set an &#34;outperform&#34; rating and a $27.00 price objective for the company. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Omada Health presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $25.10.</p>
<div class="lb-trans"><p>幾位研究分析師最近對該公司發表了評論。巴克萊將 Omada Health 的目標價從 29.00 美元下調至 22.00 美元，並在 1 月 5 日的研究報告中給予該公司 “增持” 評級。高盛集團重申了對 Omada Health 的 “買入” 評級，並在 1 月 16 日的報告中發佈了 26.00 美元的目標價。Needham &amp; Company LLC 在週四重申了 “買入” 評級，並對 Omada Health 發佈了 28.00 美元的目標價。富國銀行在 1 月 8 日的研究報告中開始覆蓋 Omada Health 的股票，給予 “持平” 評級，目標價為 17.00 美元。最後，BMO Capital Markets 在 11 月 13 日的研究報告中開始覆蓋 Omada Health 的股票，設定了 “跑贏大盤” 評級和 27.00 美元的目標價。八位投資分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，Omada Health 目前的平均評級為 “適度買入”，共識目標價為 25.10 美元。</p>
</div><p><strong>View Our Latest Research Report on Omada Health</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Omada Health 的最新研究報告</strong></p>
</div><h2>Omada Health Stock Performance</h2>
<div class="lb-trans"><h2>Omada Health 股票表現</h2>
</div><p>Omada Health stock opened at $16.52 on Friday. The stock has a market cap of $956.67 million and a PE ratio of -66.08. The stock has a 50-day moving average of $16.38 and a two-hundred day moving average of $19.88. Omada Health, Inc. has a one year low of $14.14 and a one year high of $28.40.</p>
<div class="lb-trans"><p>Omada Health 股票在週五開盤價為 16.52 美元。該股票的市值為 9.5667 億美元，市盈率為 -66.08。該股票的 50 日移動平均線為 16.38 美元，200 日移動平均線為 19.88 美元。Omada Health, Inc. 的一年低點為 14.14 美元，一年高點為 28.40 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部交易活動</h2>
</div><p>In other Omada Health news, President Wei-Li Shao sold 5,618 shares of the business's stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $16.13, for a total transaction of $90,618.34. Following the sale, the president owned 69,079 shares of the company's stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CEO Sean P. Duffy sold 230,479 shares of the company's stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $15.60, for a total transaction of $3,595,472.40. Following the transaction, the chief executive officer owned 126,644 shares in the company, valued at $1,975,646.40. The trade was a 64.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 276,893 shares of company stock worth $4,336,787.</p>
<div class="lb-trans"><p>在其他 Omada Health 的新聞中，總裁 Wei-Li Shao 於 12 月 29 日星期一出售了 5,618 股公司的股票。該股票以平均價格 16.13 美元出售，總交易額為 90,618.34 美元。出售後，總裁持有 69,079 股公司的股票，價值約 1,114,244.27 美元。此次交易使其持股減少了 7.52%。該交易已在向證券交易委員會提交的文件中披露，相關文件可在此鏈接查看。此外，首席執行官 Sean P. Duffy 於 1 月 12 日星期一出售了 230,479 股公司的股票。該股票以平均價格 15.60 美元出售，總交易額為 3,595,472.40 美元。交易後，首席執行官持有 126,644 股公司的股票，價值 1,975,646.40 美元。此次交易使其持股減少了 64.54%。有關此次出售的更多細節可在官方 SEC 披露中找到。在過去 90 天內，內部人士已出售了價值 4,336,787 美元的 276,893 股公司股票。</p>
</div><h2>Omada Health Company Profile</h2>
<div class="lb-trans"><h2>Omada Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.</p>
<div class="lb-trans"><p>Omada Health 是一家數字健康公司，專注於通過個性化的技術驅動程序預防和管理慢性疾病。該公司的平台結合了數據分析、行為科學和人類輔導，以支持面臨風險或患有如前糖尿病、2 型糖尿病、高血壓和肌肉骨骼疾病等疾病的個體。參與者通過移動應用程序或網絡門户訪問該程序，在那裏他們可以獲得量身定製的課程、健康指標反饋和持續的虛擬輔導。</p>
</div><p>In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.</p>
<div class="lb-trans"><p>除了核心的疾病管理服務外，Omada Health 還擴展了其服務，包括心理健康支持和數字治療以幫助體重管理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>The $100 Trillion AI Story No One Is Telling You</li>
<li>Buy This Stock at 9:30 AM on MONDAY!</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Omada Health 更好</li>
<li>投資者警報：微小的 “3 美元 AI 奇蹟股票” 即將爆發</li>
<li>沒有人告訴你的 100 萬億美元的 AI 故事</li>
<li>在週一上午 9:30 買入這隻股票！</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
<li>埃隆將 SpaceX 上市！100 美元的 IPO 前機會！</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=OMDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Omada Health 嗎？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Omada Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前買入……而 Omada Health 並不在名單上。</p>
</div><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Omada Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得投資。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看五隻股票</p>
</div>

Emerald Mutual Fund Advisers Trust 出售了 99,302 股 Omada Health, Inc. $OMDA